News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biocomposites Granted SFDA Clearance for geneX(R) in P.R.China



2/23/2009 8:41:58 AM

STAFFORDSHIRE, UK--(BUSINESS WIRE)--Biocomposites (www.biocomposites.com) announced today that the company’s unique bone graft substitute geneX®, has been cleared for use by the State Food and Drug Administration (SFDA) of the People's Republic of China.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES